Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006;46:101-22.
doi: 10.1146/annurev.pharmtox.46.120604.141254.

Cannabinoid Receptors as Therapeutic Targets

Affiliations
Review

Cannabinoid Receptors as Therapeutic Targets

Ken Mackie. Annu Rev Pharmacol Toxicol. .

Abstract

CB1 and CB2 cannabinoid receptors are the primary targets of endogenous cannabinoids (endocannabinoids). These G protein-coupled receptors play an important role in many processes, including metabolic regulation, craving, pain, anxiety, bone growth, and immune function. Cannabinoid receptors can be engaged directly by agonists or antagonists, or indirectly by manipulating endocannabinoid metabolism. In the past several years, it has become apparent from preclinical studies that therapies either directly or indirectly influencing cannabinoid receptors might be clinically useful. This review considers the components of the endocannabinoid system and discusses some of the most promising endocannabinoid-based therapies.

Similar articles

See all similar articles

Cited by 156 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback